Tag
3 articles tagged Protein Design.
Chai Discovery is positioning AI protein design as a neutral software factory for pharma partners. The company has partnered with Eli Lilly, Pfizer, Novartis, and Argenx to accelerate antibody and binder discovery. Its visual design suite, compute infrastructure, and partner specific fine tuning create a platform model for precision drug engineering.
Analyzes the strategic shift toward scaling laws, metagenomic data integration, and open-source distribution in AI-driven protein biology. Explores how biotech firms can leverage world models, lab-in-the-loop validation, and multi-modal data infrastructure to accelerate R&D and capture market value.
Boltz Bio founders discuss building open-source AI models to rival AlphaFold 3. They detail the shift from regression to generative modeling, the critical role of wet-lab validation, and the commercial strategy of serving scientists through a specialized platform.
